5-hydroxy-3-methylfuran-2 (5H)-ketone derivative as well as preparation method and application thereof
The problem of stimulation of root weed germination by synthesis of 5-hydroxy-3-methylfuran-2(5H)-one derivatives is solved, and an excellent monosporus analog is provided to promote seeds Germination and prevention of root weeds, with high activity, stability and environmental protection characteristics.
Patent Information
- Application Number
- CN202411162251.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-22
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-08-22
AI Technical Summary
The prior art is difficult to effectively prevent and control root weeds, especially because the monocleolide secreted by the root part of the host crop of root weeds can stimulate the germination of root weed seeds, and existing drugs lack effective solutions.
A series of 5-hydroxy-3-methylfuran-2(5H)-one derivatives were designed and synthesized, using molecular models of binding to monazole receptors through structural modification with monazole-lactone analogs. and the "native pharmacodynamic group of natural products" strategy, synthesize monosaclactone analogs with excellent activity to promote seed germination.
These nitrolactone analogs show excellent germination activity in nitro and nitroscopic seeds, are easy to degrade, low residue, environmentally friendly, and are simple and economical in synthesis, providing an effective Root weed prevention and control measures.
Smart Images

Figure QLYQS_1 
Figure QLYQS_2 
Figure QLYQS_3
Abstract
Description
Technical Field
[0001] The present invention relates to plant hormone compounds and uses thereof, in particular to strigolactone analogues 5-hydroxy-3-methylfuran-2(5H)-one derivatives and preparation methods and uses thereof. Background Art
[0002] The prevention and control of root-parasitic weeds has always been a problem that has plagued agricultural production, and there is still a lack of effective drugs to alleviate this dilemma. Studies have shown that strigolactones (SLs) secreted by the roots of the host crops of root-parasitic weeds can stimulate the germination of root-parasitic weed seeds, and if the seeds cannot parasitize within a limited time after germination, they will die. The structure of natural strigolactones contains an enol ether butenoic acid lactone structure (also known as the enol ether D ring). Systematic structure-activity relationship studies have shown that the enol ether butenoic acid lactone structure is a structural unit necessary to maintain the activity of this type of compound. Based on this, a series of natural strigolactone analogs have been synthesized. Summary of the invention
[0003] The purpose of the present invention is to provide a 5-hydroxy-3-methylfuran-2(5H)-one derivative and a preparation method and application thereof.
[0004] In order to achieve the purpose of the present invention, in the first aspect, the present invention provides a 5-hydroxy-3-methylfuran-2(5H)-one derivative, the structure of which is shown in Formula I, Formula II or Formula III:
[0005]
[0006] In Formula I, R is selected from 1a to 1y:
[0007]
[0008] In formula II, R is selected from 2a to 2i:
[0009]
[0010] In formula III, R is selected from 3a to 3t:
[0011]
[0012] In a second aspect, the present invention provides a method for preparing the 5-hydroxy-3-methylfuran-2(5H)-one derivative.
[0013] The preparation method of the compound of formula I comprises: adding a phenol derivative to a tetrahydrofuran solution of 5-chloro-3-methylfuran-2(5H)-one, cooling the temperature to 0-5°C, then adding a catalytic amount of potassium tert-butoxide, and reacting at room temperature to obtain the target compound.
[0014] The structure of the phenol derivative is R-OH, and R is selected from 1a to 1y.
[0015] Furthermore, the preparation method of the compound of formula I comprises the following steps:
[0016] Step 1: Add 118.6 mmol of methylmalonic acid and 118.6 mmol of glyoxal into a reaction bottle containing water, add 10 drops of concentrated sulfuric acid, and heat under reflux at 110-115° C. for 10-12 hours to obtain intermediate I, i.e. 5-hydroxy-3-methyl-2(5H)-furanone;
[0017] Wherein, the molar ratio of methylmalonic acid to glyoxal is 1:1.
[0018] Step 2: Add intermediate I to a reaction bottle containing DCM, slowly drop SOCl2 and then add DMF, heat under reflux at 90-95°C for 1-2h to obtain intermediate II, i.e. 5-chloro-3-methylfuran-2(5H)-one;
[0019] Step 3: Add phenol derivatives and potassium iodide to a reaction bottle containing THF under N2 protection, cool to 0-5°C, add potassium tert-butoxide, stir for 10-15 minutes, then add intermediate II, react at room temperature for 3-4 hours to obtain the target compound.
[0020] The preparation method of the compound of formula II comprises: adding a thiophenol derivative to a tetrahydrofuran solution of 5-chloro-3-methylfuran-2(5H)-one, cooling to 0-5°C, then adding a catalytic amount of potassium tert-butoxide, and reacting at room temperature to obtain the target compound.
[0021] The structure of the thiophenol derivative is R-SH, and R is selected from 2a to 2i.
[0022] Furthermore, the preparation method of the compound of formula II comprises the following steps:
[0023] Step 1: Add 118.6 mmol of methylmalonic acid and 118.6 mmol of glyoxal into a reaction bottle containing water, add 10 drops of concentrated sulfuric acid, and heat under reflux at 110-115° C. for 10-12 hours to obtain intermediate I, i.e. 5-hydroxy-3-methyl-2(5H)-furanone;
[0024] Wherein, the molar ratio of methylmalonic acid to glyoxal is 1:1.
[0025] Step 2: Add intermediate I to a reaction bottle containing DCM, slowly drop SOCl2 and then add DMF, heat under reflux at 90-95°C for 1-2h to obtain intermediate II, i.e. 5-chloro-3-methylfuran-2(5H)-one;
[0026] Step 3: Under N2 protection, add thiophenol derivatives and potassium iodide to a reaction bottle containing THF, cool to 0-5°C, add potassium tert-butoxide, stir for 10 minutes, then add intermediate II, react at room temperature for 3-4 hours to obtain the target compound.
[0027] The preparation method of the compound of formula III (R is selected from 3a to 31) comprises: adding a benzoyl chloride derivative to a dichloromethane solution of 5-hydroxy-3-methyl-2(5H)-furanone, then adding a catalytic amount of DMAP, and reacting at room temperature to obtain the target compound;
[0028] The structure of the benzoyl chloride derivative is R is selected from 3a to 31.
[0029] Furthermore, the preparation method of the compound of formula III comprises the following steps:
[0030] Step 1: Add 118.6 mmol of methylmalonic acid and 118.6 mmol of glyoxal into a reaction bottle containing water, add 10 drops of concentrated sulfuric acid, heat under reflux at 110-115° C. for 10-12 hours to obtain intermediate I, i.e. 5-hydroxy-3-methyl-2(5H)-furanone.
[0031] Wherein, the molar ratio of methylmalonic acid to glyoxal is 1:1.
[0032] Step 2: Add 1.75 mmol of intermediate I and 1.75 mmol of DMAP into a reaction bottle containing DCM, cool to 0°C, and dropwise add 1.75 mmol of a benzoyl chloride derivative dissolved in dichloromethane. After the addition is complete, react at room temperature for 3-4 hours to obtain the target compound.
[0033] Wherein, the molar ratio of intermediate I and benzoyl chloride derivative is 1:1.
[0034] The preparation method of the compound of formula III (R is selected from 3m to 3t) comprises: adding 3.5 mmol of a benzoic acid derivative to a dichloromethane solution of 1.75 mmol of 5-hydroxy-3-methyl-2(5H)-furanone, and then adding 3.5 mmol of DMAP and 3.5 mmol of EDCI in a catalytic amount, reacting at room temperature to obtain the target compound;
[0035] The structure of the benzoic acid derivative is R is selected from 3m to 3t.
[0036] Furthermore, the preparation method of the compound of formula III comprises the following steps:
[0037] Step 1: Add 118.6 mmol of methylmalonic acid and 118.6 mmol of glyoxal into a reaction bottle containing water, add 10 drops of concentrated sulfuric acid, heat under reflux at 110-115° C. for 10-12 hours to obtain intermediate I, i.e. 5-hydroxy-3-methyl-2(5H)-furanone.
[0038] Wherein, the molar ratio of methylmalonic acid to glyoxal is 1:1.
[0039] Step 2: Add 1.75mmol of intermediate I, 3.5mmol of EDCI and 3.5mmol of DMAP into a reaction bottle containing DCM, add benzoic acid derivatives dissolved in dichloromethane, and react at room temperature for 3-4h to obtain the target compound.
[0040] Wherein, the molar ratio of the intermediate I benzoic acid derivative is 1:2.
[0041] In a third aspect, the present invention provides any of the following uses of the 5-hydroxy-3-methylfuran-2(5H)-one derivative:
[0042] (1) Used to induce germination of seeds of Monochamus and Orobancha plants;
[0043] (2) Used for the prevention and control of monocotyledon and Orobancha plants.
[0044] By means of the above technical solution, the present invention has at least the following advantages and beneficial effects:
[0045] The invention designs and synthesizes novel strigolactone derivatives by using a molecular model of the binding of strigolactone to a strigolactone receptor protein and a "natural product common pharmacophore" strategy, and utilizes the alcohol ether butenoic acid lactone structure 5-hydroxy-3-methyl-2(5H)-furanone of natural strigolactone to obtain 5-chloro-3-methylfuran-2(5H)-one through chlorination. Since the chloride ions on the 5-chloro-3-methylfuran-2(5H)-one are easy to leave, it is easy to undergo substitution reaction with phenol derivatives and thiophenol derivatives. Therefore, the structure of the 5th position of 5-chloro-3-methylfuran-2(5H)-one was modified to synthesize a series of strigolactone analogues. At the same time, the hydroxyl group on 5-hydroxy-3-methyl-2(5H)-furanone was esterified with various substituted benzoyl chlorides or substituted benzoic acids to synthesize a series of strigolactone analogues. The germination activity of these compounds on the seeds of Orobanche and Strigosa argyi was determined. It was found that these compounds have excellent seed germination promoting activity, easy degradation, low residue, and environmental friendliness. The synthesis method is simple and economical, and they can be used as root parasitic weed germination agonists.
[0046] The invention provides three strigolactone analogs which have excellent activity in promoting the germination of seeds of Orobanche and Striga. Compared with existing artificially synthesized strigolactone analogs, the three strigolactone analogs have the characteristics of simple structure, high activity, high stability, etc., and the synthesis method is simple and economical. The three strigolactone analogs are a class of strigolactone analogs with great research value and can be used for the prevention and treatment of root-parasitic weeds Orobanche and Striga. DETAILED DESCRIPTION
[0047] The invention provides three methods for synthesizing strigolactone analogs and applications thereof.
[0048] The strigolactone analogues of the invention have an obvious effect of promoting seed germination of Orobanche and Striga.
[0049] The present invention adopts the following technical solution:
[0050] The present invention provides three types of strigolactone analogs:
[0051] The first type of structure is as follows (Formula I):
[0052]
[0053] The second type of structure is as follows (Formula II):
[0054]
[0055] The third type of structure is as follows (Formula III):
[0056]
[0057] The seed germination activity provided by the present invention is directed to Striga asiatica seeds and Orobancha seeds. The germination activities of compounds 1a-1y, 2a-2i, 3a-3t and the control drug Striga lactone GR24 on two different plants at a concentration of 10 ppm were determined by the plate method.
[0058] The invention provides a synthesis method of strigolactone analogs with high yield, simple method and little environmental pollution, wherein the first type structure and the second type structure can be completed by three simple reactions, and the third type structure only needs two simple reactions.
[0059] The preparation methods of compounds 1a to 1y are as follows:
[0060] Step 1: Add methylmalonic acid and 40% glyoxal to an eggplant-shaped bottle filled with water, then add 10 drops of concentrated sulfuric acid, heat under reflux at 110°C for 12 hours to obtain intermediate I: 5-hydroxy-3-methyl-2(5H)-furanone.
[0061]
[0062] Step 2: Add intermediate I to an eggplant-shaped bottle containing DCM, slowly drop SOCl2 and then add DMF, heat and reflux at 90°C for 1 hour to obtain intermediate II: 5-chloro-3-methylfuran-2(5H)-one.
[0063]
[0064] Step 3: Under N2 protection, various substituted phenols and potassium iodide were added to a three-necked flask containing THF, cooled to 0°C, potassium tert-butoxide was added, stirred for 10 minutes, and then intermediate II was added. After removing the ice bath, the reaction was allowed to react at room temperature for 3 hours.
[0065]
[0066] The preparation methods of compounds 2a to 2i are as follows:
[0067] Step 1: Add methylmalonic acid and 40% glyoxal into an eggplant-shaped bottle filled with water, and then add 10 drops of concentrated sulfuric acid. Heat and reflux at 110°C for 12 hours to obtain intermediate I: 5-hydroxy-3-methyl-2(5H)-furanone.
[0068]
[0069] Step 2: Add intermediate I into an eggplant-shaped bottle containing DCM, slowly drop SOCl2 and then add DMF, heat under reflux at 90°C for 1 h to obtain intermediate II: 5-chloro-3-methylfuran-2(5H)-one.
[0070]
[0071] Step 3: Under N2 protection, various substituted thiophenols and potassium iodide were added to a three-necked flask containing THF, cooled to 0°C in an ice bath, potassium tert-butoxide was added, stirred for 10 minutes, and then intermediate II was added. The ice bath was removed and the reaction was carried out at room temperature for 3 hours.
[0072]
[0073] The preparation methods of compounds 3a to 31 are as follows:
[0074] Step 1: Add methylmalonic acid and 40% glyoxal into an eggplant-shaped bottle filled with water, and then add 10 drops of concentrated sulfuric acid. Heat and reflux at 110°C for 12 hours to obtain intermediate I: 5-hydroxy-3-methyl-2(5H)-furanone.
[0075]
[0076] Step 2: (1) Add intermediate I 5-hydroxy-3-methyl-2(5H)-furanone and DMAP to an eggplant-shaped bottle containing DCM, cool to 0°C in an ice bath, and drop various substituted benzoyl chlorides dissolved in dichloromethane. After the dropwise addition is complete, remove the ice bath and react at room temperature for 3 hours.
[0077]
[0078] The preparation methods of compounds 3m to 3t are as follows:
[0079] Step 1: Add methylmalonic acid and 40% glyoxal into an eggplant-shaped bottle filled with water, and then add 10 drops of concentrated sulfuric acid. Heat and reflux at 110°C for 12 hours to obtain intermediate I: 5-hydroxy-3-methyl-2(5H)-furanone.
[0080]
[0081] Step 2: Add intermediate I 5-hydroxy-3-methyl-2(5H)-furanone, EDCI and DMAP into an eggplant-shaped bottle containing DCM and various substituted benzoic acids dissolved in dichloromethane, and react at room temperature for 3 h.
[0082]
[0083] The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention. Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art, and the raw materials used are all commercially available products.
[0084] Example 1 Synthesis of 5-hydroxy-3-methylfuran-2(5H)-one derivatives 1a-1y, 2a-2i, 3a-3t
[0085] Intermediate I (5-hydroxy-3-methyl-2(5H)-furanone): 7g of methylmalonic acid and 9.3mL of 40% glyoxal were added to a 100mL eggplant-shaped bottle containing 60mL of water, and 10 drops of concentrated sulfuric acid were added. The mixture was heated under reflux at 110°C for 12h and the reaction was followed by TLC until the reaction was completed. Post-treatment: After cooling to room temperature, sodium chloride was added to saturation, and the mixture was extracted with EA (100mL / time, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography (EA:PE=1:5) to obtain a yellow solid product with a yield of 75%. mp105-106°C; 1 H NMR (600MHz, cdcl3) δ6.93-6.81 (m, 1H), 6.09 (s, 1H), 1.98-1.87 (m, 3H). 13C NMR (150MHz, cdcl3) 6170.78, 145.92, 131.87, 85.21, 10.38.HRMS [ESI - ]for C 11 H9ClO3[(MH) - ], m / z Calcd: 114.0317; Found: 114.0315.
[0086] Intermediate II (5-chloro-3-methylfuran-2(5H)-one): 4.17 g of 5-hydroxy-3-methyl-2(5H)-furanone was added to a 50 mL eggplant-shaped bottle containing 10 mL of DCM, and then 1.5 mL of SOCl2 was slowly added dropwise, followed by 200 μL of DMF. The reaction was heated to reflux at 90°C for 1 h, and the reaction was followed by TLC until the reaction was completed. Post-treatment: After cooling to room temperature, 10 mL of DCM:PE (1:1) mixture was used, 20 mL of saturated sodium bicarbonate was used to quench the reaction, and DCM:PE (1:4) was extracted (20 mL / time, 3 times), the organic phase was collected, washed with saturated sodium chloride, dried with anhydrous Na2SO4, and separated and purified by column chromatography (EA:PE=1:10) to obtain a yellow oily product with a yield of 60%. mp15-16°C, 1 H NMR (600MHz, cdcl3) δ7.07 (t, J=1.8Hz, 1H), 6.53 (t, J=1.7Hz, 1H), 2.00 (t, J=1.6Hz, 3H). 13 C NMR (150MHz, cdcl3) 6173.04, 144.86, 133.50, 97.07, 10.38.HRMS [ESI - ]for C 11 H9ClO3[(MH) - ], m / z Calcd: 131.9978; Found: 131.9977.
[0087] Compound 1a: Under N2 protection, add 177 mg of phenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide to a 100 mL three-necked flask containing 20 mL of THF, cool to 0°C in an ice bath, add 212 mg of potassium tert-butoxide, stir for 10 minutes, then add 250 mg of 5-chloro-3-methylfuran-2(5H)-one, remove the ice bath, and react at room temperature for 3 hours. Follow the reaction with TLC until the reaction is complete. Post-treatment: add 5 ml of water, extract with ethyl acetate (25 mL / time, 3 times), collect the organic phase, dry with anhydrous Na2SO4, separate and purify by column chromatography PE:EA (20:1) to obtain a light yellow solid product with a yield of 91%. mp132-134°C; 1H NMR (600MHz, dmso) δ7.39 (d, J=10.0Hz, 3H), 7.13 (t, J=7.6Hz, 3H), 6.71 (s, 1H), 1.91 (s, 3H). 13 C NMR (150MHz, DMSO) δ171.37, 156.01, 144.26, 132.80, 129.82, 123.24, 116.64, 98.64, 10.16.HRMS [ESI - ]for C 11 H 10 O3[(MH) - ], m / z Calcd: 109.0630; Found: 109.0633.
[0088] Compound 1b: Under N2 protection, 326 mg of 4-bromophenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / times, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a white solid product with a yield of 95%. mp147-148°C; 1 H NMR (600MHz, dmso) δ7.63-7.45 (m, 2H), 7.38 (s, 1H), 7.14-7.00 (m, 2H), 6.68 (s, 1H), 1.91-1.85 (m, 3H). 13 C NMR (150MHz, DMSO) δ155.66, 144.42, 133.34, 132.94, 119.35, 115.35, 98.94, 10.55.HRMS [ESI-] for C 11 H9BrO3[(MH)-], m / z Calcd: 267.9735; Found: 267.726.
[0089] Compound 1c: Under N2 protection, 243 mg of 4-bromophenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / times, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a light yellow solid product with a yield of 89%. mp122-123°C; 1 H NMR (600MHz, dmso) δ7.50-7.39 (m, 2H), 7.39-7.34 (m, 1H), 7.17-7.12 (m, 2H), 6.74-6.63 (m, 1H), 1.91-1.86 (m, 3H). 13 C NMR (150MHz, dmso) δ195.08, 171.61, 155.19, 144.43, 133.34, 130.02, 127.53, 118.91, 99.02, 10.55.HRMS[O3[(MH)-], m / z Calcd: 224.0240; Found: 224.0236.
[0090] Compound 1d: Under N2 protection, 212 mg of 4-fluorophenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / times, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a white solid product with a yield of 90%. mp 133-134°C; 1 H NMR (600MHz, cdcl3) δ7.09 (ddd, J=9.1, 4.4, 2.0Hz, 2H), 7.04-6.99 (m, 2H), 6.98-6.94 (m, 1H), 6.23-6.19 (m, 1H), 2.00 (t, J=2.0Hz, 4H). 13C NMR (150MHz, DMSO) δ171.66, 159.32, 157.74, 152.59, 144.50, 133.30, 119.06, 116.71, 116.55, 99.61, 10.52.HRMS [ESI-] for C 11 H9FO3[(MH)-], m / z Calcd: 208.1884; Found: 208.1885.
[0091] Compound 1e: Under N2 protection, add 287 mg of methyl p-hydroxybenzoate, 1 g of 4A molecular sieves, and 31 mg of potassium iodide to a 100 mL three-necked flask containing 20 mL of THF, cool to 0°C in an ice bath, add 212 mg of potassium tert-butoxide, stir for 10 minutes, then add 250 mg of 5-chloro-3-methylfuran-2(5H)-one, remove the ice bath, and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: add 5 ml of water, extract with ethyl acetate (25 mL / time, 3 times), collect the organic phase, dry with anhydrous Na2SO4, separate and purify by column chromatography PE:EA (20:1) to obtain a white solid product with a yield of 89%. mp112-113°C; 1 H NMR (600MHz, dmso) δ7.99 (dd, J=8.7, 2.8Hz, 2H), 7.43 (s, 1H), 7.25 (d, J=8.7Hz, 2H), 6.84 (s, 1H), 3.84 (d, J=2.7Hz, 3H), 1.95-1.89 (m, 3H). 13 C NMR (150MHz, DMSO) δ171.56, 166.08, 160.02, 144.36, 133.39, 131.79, 124.79, 116.69, 98.30, 52.44, 10.56.HRMS [ESI-] for C 13 H 12 O5(MH)-], m / z Calcd: 248.0685; Found: 248.0684.
[0092] Compound 1f: Under N2 protection, 257 mg of 2-hydroxy-4-methylbenzaldehyde, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / times, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a white solid product with a yield of 92%. mp 125-126°C; 1 H NMR (600MHz, cdcl3) δ7.05-6.79 (m, 1H), 6.75 (d, J=3.8Hz, 3H), 6.26 (s, 1H), 2.30 (d, J=3.3Hz, 6H), 2.02-1.98 (m, 3H). 13 C NMR (150MHz, DMSO) δ171.79, 156.51, 144.71, 139.49, 133.07, 125.12, 114.66, 99.12, 21.38, 10.53.HRMS [ESI-] for C 13 H 14 O3(MH)-], m / z Calcd: 218.2520; Found: 218.2522.
[0093] Compound 1g: Under N2 protection, add 231 mg of 3,5-dimethylphenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide to a 100 mL three-necked flask containing 20 mL of THF, cool to 0°C in an ice bath, add 212 mg of potassium tert-butoxide, stir for 10 minutes, then add 250 mg of 5-chloro-3-methylfuran-2(5H)-one, remove the ice bath, and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: add 5 ml of water, extract with ethyl acetate (25 mL / time, 3 times), collect the organic phase, dry with anhydrous Na2SO4, separate and purify by column chromatography PE:EA (20:1) to obtain a white solid product with a yield of 94%. mp125-126°C; 1 H NMR (600MHz, cdcl3) δ7.05-6.79 (m, 1H), 6.75 (d, J=3.8Hz, 3H), 6.26 (s, 1H), 2.30 (d, J=3.3Hz, 6H), 2.02-1.98 (m, 3H). 13C NMR (150MHz, DMSO) δ171.79, 156.51, 144.71, 139.49, 133.07, 125.12, 114.66, 99.12, 21.38, 10.53.HRMS [ESI - ]for C 13 H 14 O3(MH) - ], m / z Calcd: 218.2520; Found: 218.2522.
[0094] Compound 1h: Under N2 protection, add 263 mg of 4-nitrophenol, 1 g of 4A molecular sieve, and 31 mg of potassium iodide to a 100 mL three-necked flask containing 20 mL of THF, cool to 0°C in an ice bath, add 212 mg of potassium tert-butoxide, stir for 10 minutes, then add 250 mg of 5-chloro-3-methylfuran-2(5H)-one, remove the ice bath, and react at room temperature for 3 hours. Follow the reaction with TLC until the reaction is complete. Post-treatment: add 5 ml of water, extract with ethyl acetate (25 mL / time, 3 times), collect the organic phase, dry with anhydrous Na2SO4, separate and purify by column chromatography PE:EA (20:1) to obtain a yellow solid with a yield of 85%. mp115-116°C; 1 H NMR (600MHz, dmso) δ8.29 (dd, J=9.1, 3.5Hz, 2H), 7.46 (s, 1H), 7.36 (dd, J=9.3, 3.4Hz, 2H), 6.91 (s, 1H), 1.96-1.89 (m, 3H). 13 C NMR (150MHz, DMSO) δ171.40, 161.22, 144.13, 143.16, 133.60, 126.40, 117.26, 98.19, 10.58.HRMS [ESI - ]for C 11 H9NO5[(MH) - ], m / z Calcd: 235.0481; Found: 235.0475.
[0095] Compound 1i: Under N2 protection, add 231 mg of p-hydroxybenzaldehyde, 1 g of 4A molecular sieves, and 31 mg of potassium iodide to a 100 mL three-necked flask containing 20 mL of THF, cool to 0°C in an ice bath, add 212 mg of potassium tert-butoxide, stir for 10 minutes, then add 250 mg of 5-chloro-3-methylfuran-2(5H)-one, remove the ice bath, and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: add 5 ml of water, extract with ethyl acetate (25 mmL / time, 3 times), collect the organic phase, dry with anhydrous Na2SO4, separate and purify by column chromatography PE:EA (20:1) to obtain a yellow oily product with a yield of 90%. mp12-14°C; 1 H NMR (600MHz, dmso) δ9.92 (d, J=2.9Hz, 1H), 7.93 (dd, J=8.4, 2.9Hz, 2H), 7.43 (s, 1H), 7.31 (dd, J=8.5, 2.7Hz, 2H), 6.86 (s, 1H), 1.91 (s, 3H). 13 C NMR (150MHz, DMSO) δ191.98, 171.54, 160.92, 144.32, 133.46, 132.24, 132.02, 117.07, 98.18, 10.57.HRMS [ESI - ]for C 12 H 10 O4[(MH) - ], m / zCalcd: 218.0579; Found: 218.0573.
[0096] Compound 1j: Under N2 protection, 306 mg of 4-trifluoromethylphenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / times, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a white solid product with a yield of 92%. mp 142-143°C; 1 H NMR (600MHz, dmso) δ9.92 (d, J=2.9Hz, 1H), 7.93 (dd, J=8.4, 2.9Hz, 2H), 7.43 (s, 1H), 7.31 (dd, J=8.5, 2.7Hz, 2H), 6.86 (s, 1H), 1.91 (s, 3H). 13C NMR (150MHz, DMSO) δ191.98, 171.54, 160.92, 144.32, 133.46, 132.24, 132.02, 117.07, 98.18, 10.57.HRMS [ESI - ]for C 12 H 10 O4[(MH) - ], m / z Calcd: 218.0579; Found: 218.0573.
[0097] Compound 1k: Under N2 protection, 325 mg of 4-methylsulfonylphenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / times, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a yellow solid product with a yield of 91%. mp 135-136°C; 1 H NMR (600MHz, dmso) δ 8.00-7.85 (m, 2H), 7.53-7.42 (m, 1H), 7.41-7.34 (m, 2H), 6.93-6.85 (m, 1H). 13 C NMR (151MHz, DMSO) δ171.48, 159.95, 144.25, 135.69, 133.51, 129.83, 117.26, 98.28, 44.27, 10.57.HRMS [ESI-] for C 12 H 12 O5S[(MH)-], m / z Calcd: 268.2830; Found: 268.2825.
[0098] Compound 11: Under N2 protection, 284 mg of 4-tert-butylphenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / times, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a yellow solid product with a yield of 91%. mp 141-142°C; 1 H NMR (600MHz, dmso) δ7.36 (dt, J=9.0, 2.6Hz, 3H), 7.03 (dt, J=9.3, 2.9Hz, 2H), 6.69-6.54 (m, 1H), 1.88 (s, 3H), 1.25 (d, J=3.4Hz, 9H). 13 C NMR (150MHz, DMSO) δ171.79, 154.23, 146.00, 144.73, 133.14, 126.79, 116.60, 99.32, 34.41, 31.71, 10.56.HRMS [ESI - ]for C 15 H 18 O3(MH) - ], m / zCalcd: 246.1256; Found: 246.1259.
[0099] Compound 1mm: Under N2 protection, 321 mg of 4-hydroxybiphenyl, 1 g of 4A molecular sieve, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / time, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a white solid product with a yield of 89%. mp 135-136°C; 1H NMR (600MHz, dmso) δ7.69-7.65 (m, 2H), 7.62 (d, J=7.5Hz, 2H), 7.44 (d, J=8.6Hz, 2H), 7.42 -7.39 (ml, 1H), 7.32 (t, J=7.4Hz, 1H), 7.23-7.16 (m, 2H), 6.74 (s, 1H), 1.93-1.86 (m, 3H). 13 C NMR (150MHz, DMSO) δ171.74, 155.98, 144.60, 139.88, 135.67, 133.26, 129.35, 128.45, 127.59, 126.86, 117.48, 99.05, 10.57.HRMS [ESI - ]for C 17 H 14 O3[(MH) - ], m / z Calcd: 266.0943; Found: 266.0935.
[0100] Compound 1n: Under N2 protection, 234 mg of 3-methoxyphenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / times, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a yellow oily product with a yield of 92%. mp 16-17°C; 1 H NMR (600MHz, dmso) δ7.37 (s, 1H), 7.25 (t, J=7.9Hz, 1H), 6.68 (dd, J=15.2, 8.8Hz, 4H), 3.78-3.68 (m, 3H), 1.88 (s, 3H). 13 C NMR (150MHz, dmso) δ171.74, 160.94, 157.53, 144.58, 133.17, 130.72, 109.31, 108.97, 103.31, 98.94, 55.74, 10.54.HRMS [ESI - ]for C 12 H 12 O4[(MH) - ], m / z Calcd: 220.0736; Found: 220.0725.
[0101] Compound 1o: Under N2 protection, add 2-naphthol 272mg, 4A molecular sieve 1g, potassium iodide 31mg to a 100mL three-necked flask containing 20mL THF, cool to 0℃ in an ice bath, add potassium tert-butoxide 212mg, stir for 10 minutes, then add 5-chloro-3-methylfuran-2(5H)-one 250mg, remove the ice bath and react at room temperature for 3h, and track the reaction by TLC until the reaction is completed. Post-treatment: add 5ml water, extract with ethyl acetate (25mL / time, 3 times), collect the organic phase, dry with anhydrous Na2SO4, separate and purify by column chromatography PE:EA (20:1) to obtain a white solid product with a yield of 95%. mp119-120℃; 1 H NMR (600MHz, dmso) δ7.38 (dt, J=3.8, 1.8Hz, 1H), 7.20 (dd, J=8.7, 2.3Hz, 2H), 7.08-6.97 (m, 2H), 6.65 (d, J=2.5Hz, 1H), 2.57 (q, J=7.6Hz, 2H), 1.92-1.83 (m, 3H), 1.16 (t, J=7.5Hz, 3H). 13 C NMR (150MHz, DMSO) δ171.75, 154.45, 144.64, 139.06, 133.11, 129.29, 117.04, 99.34, 27.75, 16.14, 10.50.HRMS [ESI - ]for C 15 H 12 O3[(MH) - ], m / z Calcd: 240.0786; Found: 240.0785.
[0102] Compound 1p: Under N2 protection, 180 mg of 4-hydroxypyridine, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / times, 3 times), the organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a white solid product with a yield of 90%. mp126-127°C; 1 H NMR (600MHz, dmso) δ7.69 (d, J=7.3Hz, 2H), 7.38 (s, 1H), 6.75 (s, 1H), 6.11 (d, J=7.1Hz, 2H), 1.97-1.84 (m, 3H).13 C NMR (150MHz, DMSO) δ171.46, 143.19, 139.16, 134.89, 118.35, 90.06, 10.88.HRMS [ESI - ]for C 10 H9NO3[(MH) - ], m / z Calcd: 191.0582; Found: 191.0574.
[0103] Compound 1q: Under N2 protection, 204 mg of 4-methylphenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / times, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a white solid product with a yield of 92%. mp 120-121°C; 1 H NMR (600MHz, dmso) δ7.43-7.29 (m, 1H), 7.17 (d, J=8.0Hz, 2H), 7.06-6.93 (m, 2H), 6.70-6.59 (m, 1H), 2.27 (s, 3H), 1.95-1.82 (m, 3H). 13 C NMR (150MHz, DMSO) δ171.77, 154.29, 144.66, 133.14, 132.65, 130.48, 117.07, 99.38, 20.57, 10.52.HRMS [ESI - ]for C 12 H 12 O3(MH) - ], m / z Calcd: 204.2250; Found: 204.2249.
[0104] Compound 1r: Under N2 protection, 231 mg of 4-ethylphenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / times, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a white solid product with a yield of 88%. mp 129-130°C; 1 H NMR (600MHz, dmso) δ7.38 (dt, J=3.8, 1.8Hz, 1H), 7.20 (dd, J=8.7, 2.3Hz, 2H), 7.08-6.97 (m, 2H), 6.65 (d, J=2.5Hz, 1H), 2.57 (q, J=7.6Hz, 2H), 1.92-1.83 (m, 3H), 1.16 (t, J=7.5Hz, 3H). 13 C NMR (150MHz, DMSO) δ171.75, 154.45, 144.64, 139.06, 133.11, 129.29, 117.04, 99.34, 27.75, 16.14, 10.50.HRMS [ESI - ]for C 13 H 14 O3[(MH) - ], m / z Calcd: 218.0943; Found: 218.0942.
[0105] Compound 1s: Under N2 protection, 257 mg of 2,3,5-trimethylphenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / times, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a white solid product with a yield of 90%. mp 138-139°C; 1H NMR (600MHz, dmso) δ7.41 (s, 1H), 6.88 (s, 1H), 6.76 (s, 1H), 6.54 (s, 1H), 2.25 (s, 3H), 2.19 (s, 3H), 2.03 (s, 3H), 1.91 (s, 3H). 13 C NMR (150MHz, cdcl3) δ171.53, 154.70, 142.56, 138.08, 136.03, 134.27, 126.03, 114.31, 100.09, 21.07, 19.96, 11.60, 10.58.HRMS [ESI - ]for C 14 H 16 O3[(MH) - ], m / z Calcd: 232.1099; Found: 232.1088.
[0106] Compound 1t: Under N2 protection, add 274 mg of 6-hydroxyisoquinoline, 1 g of 4A molecular sieves, and 31 mg of potassium iodide to a 100 mL three-necked flask containing 20 mL of THF, cool to 0°C in an ice bath, add 212 mg of potassium tert-butoxide, stir for 10 minutes, then add 250 mg of 5-chloro-3-methylfuran-2(5H)-one, remove the ice bath, and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: add 5 ml of water, extract with ethyl acetate (25 mL / time, 3 times), collect the organic phase, dry with anhydrous Na2SO4, separate and purify by column chromatography PE:EA (20:1) to obtain a yellow oily product with a yield of 92%. mp10-11°C; 1 H NMR (600MHz, dmso) δ9.32 (s, 1H), 8.52 (d, J=5.8Hz, 1H), 7.87 (dd, J=10.1, 7. 0Hz, 2H), 7.67 (t, J=8.0Hz, 1H), 7.63-7.47 (m, 2H), 6.89 (s, 1H), 1.94 (s, 3H). 13 C NMR (150MHz, DMSO) δ171.64, 152.45, 150.98, 144.51, 143.51, 133.50, 129.45, 128.09, 122.71, 114.61, 114.24, 99.37, 10.64.HRMS [ESI - ]for C 14 H 11 NO3[(MH) - ], m / z Calcd: 241.0739; Found: 241.0726
[0107] Compound 1u: Under N2 protection, add 206 mg of 4-aminophenol, 1 g of 4A molecular sieve, and 31 mg of potassium iodide to a 100 mL three-necked flask containing 20 mL of THF, cool to 0°C in an ice bath, add 212 mg of potassium tert-butoxide, stir for 10 minutes, then add 250 mg of 5-chloro-3-methylfuran-2(5H)-one, remove the ice bath, and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: add 5 ml of water, extract with ethyl acetate (25 mL / time, 3 times), collect the organic phase, dry with anhydrous Na2SO4, separate and purify by column chromatography PE:EA (20:1) to obtain a white solid product with a yield of 92%. mp156-157°C; 1 H NMR (600MHz, dmso) δ7.29 (s, 1H), 6.79 (dd, J=9.2, 3.2Hz, 2H), 6.51 (dd, J=9.2, 3.2Hz, 2H), 6.39 (s, 1H), 4.92 (s, 2H), 1.84 (s, 3H). 13 C NMR (150MHz, DMSO) δ171.90, 147.18, 145.21, 144.87, 133.01, 118.96, 115.04, 100.81, 10.52.HRMS [ESI - ]for C 11 H 11 NO3[(MH) - ], m / z Calcd: 205.0739; Found: 250.0736.
[0108] Compound 1v: Under N2 protection, add 243 mg of 3-chlorophenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide to a 100 mL three-necked flask containing 20 mL of THF, cool to 0°C in an ice bath, add 212 mg of potassium tert-butoxide, stir for 10 minutes, then add 250 mg of 5-chloro-3-methylfuran-2(5H)-one, remove the ice bath, and react at room temperature for 3 hours. Follow the reaction with TLC until the reaction is complete. Post-treatment: add 5 ml of water, extract with ethyl acetate (25 mL / time, 3 times), collect the organic phase, dry with anhydrous Na2SO4, separate and purify by column chromatography PE:EA (20:1) to obtain a white solid product with a yield of 91%. mp143-144°C; 1 H NMR (600MHz, dmso) δ7.41 (q, J=7.0Hz, 2H), 7.26-7.21 (m, 1H), 7.21-7.16 (m, 1H), 7.14-7.08 (m, 1H), 6.79-6.73 (m, 1H), 1.97-1.83 (m, 3H). 13C NMR (150MHz, cdcl3) δ171.27, 157.28, 142.21, 135.35, 134.97, 130.80, 124.09, 117.85, 115.46, 98.99, 10.87.HRMS [ESI - ]for C 11 H9ClO3[(MH) - ], m / z Calcd: 224.0240; Found: 224.0239.
[0109] Compound 1w: Under N2 protection, 3.4-dichlorophenol 308mg, 4A molecular sieve 1g, potassium iodide 31mg were added to a 100mL three-necked flask containing 20mL THF, and the mixture was cooled to 0℃ in an ice bath. Potassium tert-butoxide 212mg was added, and stirred for 10 minutes, and then 5-chloro-3-methylfuran-2(5H)-one 250mg was added. The ice bath was removed and the mixture was reacted at room temperature for 3h. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5ml of water was added, and the mixture was extracted with ethyl acetate (25mL / time, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography PE:EA (20:1) to obtain a white solid product with a yield of 93%. mp138-139℃; 1 H NMR (600MHz, dmso) δ7.61 (dd, J=8.8, 3.0Hz, 1H), 7.44 (d, J=3.0Hz, 1H), 7.41-7.36 (m, 1H), 7.14 (dd, J=8.9, 3.0 Hz, 1H), 6.82-6.69 (m, 1H), 1.91-1.83 (m, 3H). 13 C NMR (150MHz, cdcl3) δ170.81, 155.23, 141.71, 134.87, 133.21, 130.91, 127.25, 119.17, 116.69, 98.78, 10.59.HRMS [ESI - ]for C 11 H8Cl2O3[(MH) - ], m / z Calcd: 257.9850; Found: 257.9843.
[0110] Compound 1x: Under N2 protection, add 308 mg of 3.5-dichlorophenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide to a 100 mL three-necked flask containing 20 mL of THF, cool to 0°C in an ice bath, add 212 mg of potassium tert-butoxide, stir for 10 minutes, then add 250 mg of 5-chloro-3-methylfuran-2(5H)-one, remove the ice bath, and react at room temperature for 3 hours. Follow the reaction with TLC until the reaction is complete. Post-treatment: add 5 ml of water, extract with ethyl acetate (25 mL / time, 3 times), collect the organic phase, dry with anhydrous Na2SO4, separate and purify by column chromatography PE:EA (20:1) to obtain a white solid product with a yield of 93%. mp147-149°C; 1 H NMR (600MHz, dmso) δ7.41-7.36 (m, 1H), 7.38-7.31 (m, 1H), 7.23 (d, J=2.1Hz, 2H), 6.80 (s, 1H), 1.92-1.85 (m, 3H). 13 C NMR (150MHz, DMSO) δ171.38, 157.53, 144.07, 135.20, 133.56, 123.38, 116.28, 98.55, 10.54.HRMS [ESI - ]for C 11 H8C12O3[(MH) - ], m / z Calcd: 257.9850; Found: 257.9839.
[0111] Compound 1y: Under N2 protection, 308 mg of 2.3-dichlorophenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / time, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a white solid product with a yield of 95%. mp 125-126°C; 1 H NMR (600MHz, dmso) δ7.47-7.40 (m, 1H), 7.39 (d, J=3.4Hz, 3H), 6.77 (s, 1H), 1.96-1.84 (m, 3H). 13C NMR (150MHz, cdcl3) δ170.80, 153.39, 141.73, 134.99, 134.07, 127.62, 125.66, 123.77, 116.75, 99.59, 10.58.HRMS [ESI - ]for C 11 H8Cl2o3[(MH) - ], m / z Calcd: 257.9850; Found: 257.9853.
[0112] Compound 2a: Under N2 protection, 242 mg of 4-fluorobenzenethiol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / time, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a light yellow solid product with a yield of 85%. mp 125-126°C; 1 H NMR (600MHz, cdcl3) δ7.54-7.48 (m, 2H), 7.07-7.00 (m, 2H), 6.93 (q, J=1.6Hz, 1H), 6.03 (q, J=1.9Hz, 1H), 1.82 (t, J=1.8Hz, 3H). 13 C NMR (150MHz, cdcl3) δ172.45, 164.32, 162.66, 144.72, 136.85, 136.79, 132.12, 124.76, 116.35, 85.60, 10.37.HRMS [ESI - ]for C 11 H9FO2S[(MH) - ], m / zCalcd: 224.0307; Found: 224.0301
[0113] Compound 2b: Under N2 protection, 357 mg of 4-bromobenzenethiol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / times, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a yellow solid product with a yield of 82%. mp118-119°C; 1 H NMR (600MHz, cdcl3) δ7.50-7.44 (m, 2H), 7.41-7.35 (m, 2H), 6.95 (p, J=1.7Hz, 1H), 6.07 (p, J=1.9Hz, 1H), 1.86 (t, J=1.8Hz, 3H). 13 C NMR (150MHz, cdcl3) δ172.37, 144.45, 135.37, 132.42, 132.30, 129.32, 123.64, 85.41, 10.46.HRMS [ESI - ]for C 11 H9BrO2S[(MH) - ], m / z Calcd: 285.1550; Found: 285.1543.
[0114] Compound 2c: Under N2 protection, 23 mg of 2-methylthiophenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / times, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a yellow oily product with a yield of 88%. mp14-15℃; 1H NMR (600MHz, cdcl3) δ7.57-7.54 (m, 1H), 7.25-7.19 (m, 2H), 7.17 (td, J=7.1, 2.4Hz, 1 H), 6.98 (p, J=1.7Hz, 1H), 6.09 (p, J=1.9Hz, 1H), 2.46 (s, 3H), 1.85 (t, J=1.8Hz, 3H). 13C NMR (150MHz, cdcl3) δ172.61, 144.68, 141.22, 134.89, 131.84, 130.62, 129.70, 129.15, 126.68, 85.80, 21.04, 10.45.HRMS [ESI - ]for C 12 H 12 02S[(MH) - ], m / z Calcd: 220.0558; Found: 220.0549.
[0115] Compound 2d: Under N2 protection, 265 mg of 4-methoxybenzenethiol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / time, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a yellow solid product with a yield of 89%. mp123-124°C; 1 H NMR (600MHz, cdcl3) δ7.44-7.41 (m, 2H), 6.91 (p, J=1.6Hz, 1H), 6.86-6.82 (m, 2H), 5.99 (p, J=1.9Hz, 1H), 3.80 (s, 3H), 1.79 (t, J=1.8Hz, 3H). 13 C NMR (150MHz, cdcl3) δ172.72, 160.74, 145.13, 136.90, 131.65, 119.61, 114.61, 85.93, 55.34, 10.35.HRMS [ESI - ]for C 12 H 12 O3S[(MH) - ], m / z Calcd: 236.0507; Found: 236.0493.
[0116] Compound 2e: Under N2 protection, 314 mg of 4-tert-butylthiophenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / times, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a yellow solid product with a yield of 81%. mp 135-136°C; 1 H NMR (600MHz, cdcl3) δ7.47-7.42 (m, 2H), 7.36-7.32 (m, 2H), 6.95-6.93 (m, 1H), 6.07 (p, J=1.9Hz, 1H), 1.81 (t, J=1.8Hz, 3H), 1.30 (d, J=0.7Hz, 9H). 13 C NMR (150MHz, cdcl3) δ172.69, 152.53, 144.87, 133.70, 131.83, 126.57, 126.15, 85.98, 34.66, 31.16, 10.35.HRMS [ESI - ]forC 15 H 18 O2S[(MH) - ], m / z Calcd: 262.1028; Found: 262.1019.
[0117] Compound 2f: Under N2 protection, 302 mg of 2-naphthol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide were added to a 100 mL three-necked flask containing 20 mL of THF, and the mixture was cooled to 0°C in an ice bath. 212 mg of potassium tert-butoxide was added, and stirred for 10 minutes, followed by 250 mg of 5-chloro-3-methylfuran-2(5H)-one. The ice bath was removed and the mixture was reacted at room temperature for 3 hours. The reaction was followed by TLC until the reaction was completed. Post-treatment: 5 ml of water was added, and the mixture was extracted with ethyl acetate (25 mL / times, 3 times). The organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (20:1) to obtain a yellow solid product with a yield of 90%. mp124-125°C; 1H NMR (600MHz, cdcl3) δ8.05 (d, J=1.8Hz, 1H), 7.86-7.76 (m, 3H), 7.56 (dd, J=8.5, 1.9Hz, 1H), 7. 52 (dt, J=6.2, 3.4Hz, 2H), 7.01 (t, J=1.6Hz, 1H), 6.19 (p, J=1.9Hz, 1H), 1.82 (t, J=1.8Hz, 3H). 13 C NMR (150MHz, cdcl3) δ172.63, 144.72, 133.47, 133.24, 133.01, 132.16, 130. 24, 128.77, 127.79, 127.75, 127.71, 126.97, 126.79, 85.99, 10.43.HRMS [ESI - ]for C 15 H 18 O2S[(MH) - ], m / z Calcd: 256.0558; Found: 256.0846.
[0118] Compound 2g: Under N2 protection, add 273 mg of 4-chlorobenzenethiol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide to a 100 mL three-necked flask containing 20 mL of THF, cool to 0°C in an ice bath, add 212 mg of potassium tert-butoxide, stir for 10 minutes, then add 250 mg of 5-chloro-3-methylfuran-2(5H)-one, remove the ice bath, and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: add 5 ml of water, extract with ethyl acetate (25 mL / time, 3 times), collect the organic phase, dry with anhydrous Na2SO4, separate and purify by column chromatography PE:EA (20:1) to obtain a white solid product with a yield of 88%. mp147-148°C; 1 H NMR (600MHz, cdcl3) δ7.48-7.44 (m, 2H), 7.33-7.30 (m, 2H), 6.95 (p, J=1.7Hz, 1H), 6.07 (p, J=1.9Hz, 1H), 1.86 (t, J=1.8Hz, 3H). 13 C NMR (150MHz, cdcl3) δ172.38, 144.51, 135.52, 135.08, 132.35, 129.33, 128.56, 85.48, 10.43.HRMS [ESI - ]for C 11 H9O2S[(MH) - ], m / z Calcd: 240.0012; Found: 240.0003.
[0119] Compound 2h: Under N2 protection, add 261 mg of 2,5-dimethylthiophenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide to a 100 mL three-necked flask containing 20 mL of THF, cool to 0°C in an ice bath, add 212 mg of potassium tert-butoxide, stir for 10 minutes, then add 250 mg of 5-chloro-3-methylfuran-2(5H)-one, remove the ice bath, and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: add 5 ml of water, extract with ethyl acetate (25 mL / time, 3 times), collect the organic phase, dry with anhydrous Na2SO4, separate and purify by column chromatography PE:EA (20:1) to obtain a yellow solid product with a yield of 85%. mp124-125°C; 1 H NMR (600MHz, cdcl3) δ7.38 (d, J=1.8Hz, 1H), 7.11 (d, J=7.7Hz, 1H), 7.05 (dd, J=7.8, 1.8Hz, 1H) , 6.99 (p, J=1.5Hz, 1H), 6.09 (q, J=1.9Hz, 1H), 2.41 (s, 3H), 2.30 (s, 3H), 1.86 (t, J=1.8Hz, 3H). 13 C NMR (150MHz, cdcl3) δ172.68, 144.68, 137.78, 136.41, 135.11, 131.84, 130.37, 129.55, 85.97, 20.72, 20.50, 10.42.HRMS [ESI - ]for C 13 H 14 O2S[(MH) - ], m / z Calcd: 234.0715; Found: 234.0709.
[0120] Compound 2i: Under N2 protection, add 288 mg of 4-isopropylthiophenol, 1 g of 4A molecular sieves, and 31 mg of potassium iodide to a 100 mL three-necked flask containing 20 mL of THF, cool to 0°C in an ice bath, add 212 mg of potassium tert-butoxide, stir for 10 minutes, then add 250 mg of 5-chloro-3-methylfuran-2(5H)-one, remove the ice bath, and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: add 5 ml of water, extract with ethyl acetate (25 mL / time, 3 times), collect the organic phase, dry with anhydrous Na2SO4, separate and purify by column chromatography PE:EA (20:1) to obtain a yellow oily product with a yield of 89%. mp5-6°C; 1H NMR (600MHz, cdcl3) δ7.46-7.42 (m, 2H), 7.21-7.16 (m, 2H), 6.93 (q, J=1.8Hz, 1H), 6.12 -6.03 (m, 1H), 2.89 (p, J=7.2Hz, 1H), 1.81 (d, J=2.0Hz, 3H), 1.23 (dd, J=7.2, 2.0Hz, 6H). 13 C NMR (150MHz, cdcl3) δ172.71, 150.29, 144.92, 134.40, 131.81, 127.26, 126.71, 85.98, 33.84, 23.59, 10.35.HRMS [ESI - ]for C 12 H 12 O5S[(MH) - ], m / z Calcd: 268.0405; Found: 268.0394.
[0121] Compound 3a: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone and 214 mg of DMAP to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 246 mg of benzoyl chloride dissolved in DCM. After the addition is complete, remove the ice bath and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it over anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a white solid product with a yield of 89%. mp122-126°C; 1 H NMR (600MHz, cdcl3) δ 8.18-7.97 (m, 2H), 7.61 (q, J=5.8Hz, 1H), 7.46 (t, J=7.6Hz, 2H), 7.16-7.07 (m, 1H), 7.06-6.99 (m, 1H), 2.20-1.93 (m, 3H). 13 C NMR (150MHz, cdcl3) δ171.07, 164.74, 142.12, 134.57, 133.99, 130.05, 128.58, 128.43, 93.03, 10.64.HRMS [ESI-] forC 12 H 10 O4[(MH)-], m / zCalcd: 218.21; Found: 218.18.
[0122] Compound 3b: 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone and 214 mg of DMAP were added to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cooled to 0°C in an ice bath, and 306 mg of 4-chlorobenzoyl chloride dissolved in DCM was added dropwise. After the addition was complete, the ice bath was removed and the mixture was reacted at room temperature for 3 h. The reaction was followed by TLC until the reaction was completed. Post-treatment: 10 mL of saturated sodium chloride aqueous solution was added for extraction, the organic phase was collected, dried over anhydrous Na2SO4, and separated and purified by column chromatography with PE:EA (10:1) to obtain a white solid product with a yield of 91%. mp 142-145°C; 1 H NMR (600MHz, cdcl3) δ7.97 (td, J=6.4, 2.8Hz, 2H), 7.50-7.36 (m, 2H), 7.14-7.05 (m, 1H), 7.03-6.95 (m, 1H), 2.08-1.95 (m, 3H). 13 C NMR (150MHz, cdcl3) δ170.87, 163.91, 141.86, 140.63, 134.73, 131.40, 128.99, 126.88, 93.08, 10.62.HRMS [ESI - ]forC 12 H9ClO4[(MH) - ], m / zCalcd: 252.65; Found: 252.62.
[0123] Compound 3c: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone and 214 mg of DMAP to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 277 mg of 4-fluorobenzoyl chloride dissolved in DCM. After the addition is complete, remove the ice bath and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it over anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a white solid product with a yield of 85%. mp143-144°C; 1 H NMR (600MHz, cdcl3) δ8.06 (dd, J=8.8, 5.6Hz, 2H), 7.18-7.05 (m, 3H), 7.02 (d, J=2.6Hz, 1H), 2.09-1.96 (m, 3H). 13 C NMR (150MHz, cdcl3) δ170.93, 167.21, 165.51, 163.75, 141.94, 134.68, 132.70, 124.67, 115.93, 115.78, 93.03, 10.61.HRMS [ESI- ]forC 12 H9FO4[(MH) - ], m / zCalcd: 236.20; Found: 236.16.
[0124] Compound 3d: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone and 214 mg of DMAP to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 270 mg of 4-methylbenzoyl chloride dissolved in DCM. After the addition is complete, remove the ice bath and react at room temperature for 3 hours. Follow the reaction with TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it with anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a white solid product with a yield of 92%. mp124-125°C; 1 H NMR (600MHz, cdcl3) δ7.97-7.90 (m, 2H), 7.27 (s, 2H), 7.12 (s, 1H), 7.06-6.99 (m, 1H), 2.43 (s, 3H), 2.04 (s, 3H). 13 C NMR (150MHz, cdcl3) δ171.14, 164.76, 144.95, 142.25, 134.47, 130.10, 129.30, 125.65, 125.65, 92.95, 21.71, 10.63.HRMS [ESI - ]forC 13 H 12 O4[(MH)-], m / zCalcd: 232.24; Found: 232.18.
[0125] Compound 3e: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone and 214 mg of DMAP to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 333 mg of 2-naphthoyl chloride dissolved in DCM. After the addition is complete, remove the ice bath and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it over anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a white solid product with a yield of 94%. mp135-136°C; 1H NMR (600MHz, cdcl3) δ8.62 (s, 1H), 8.04 (dd, J=8.7, 2.2Hz, 1H), 7.96 (d, J=8.1Hz, 1H), 7.90 (t, J=7.3Hz, 2H), 7.63 (t, J=7.5Hz, 1H), 7.57 (t, J=7.7Hz, 1H), 7.19 (s, 1H), 7.12-7.04 (m, 1H), 2.06 (d, J=2.4Hz, 3H). 13 C NMR(150MHz,cdcl3)δ171.07,64.91,142.15,135.96,134.62,132.38,132.02,1 29.46,128.84,128.46,127.81,126.92,125.61,125.08,93.16,10.66.HRMS[ESI - ]forC 16 H 12 O4[(MH)-], m / zCalcd: 268.27; Found: 268.22.
[0126] Compound 3f: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone and 214 mg of DMAP to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 306 mg of 3-chlorobenzoyl chloride dissolved in DCM. After the addition is complete, remove the water bath and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it over anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a white solid product with a yield of 81%. mp149-151°C; 1 H NMR (600MHz, cdcl3) δ8.02 (d, J=2.2Hz, 1H), 7.94 (d, J=7.7Hz, 1H), 7.59 (d, J=7.9Hz, 1H), 7.42 (ddt, J=10.2, 4.8, 2.2Hz, 1H), 7.10 (s, 1H), 7.03 (d, J=2.6Hz, 1H), 2.06-2.02 (m, 3H). 13 C NMR (150MHz, cdcl3) δ170.78,164.81,145.92,135.1,134.85,133.56,131.87,131.06,128.47,85.20,10.40.HRMS[ESI - ]forC 12 H9C1O4[(MH) -], m / zCalcd: 252.65; Found: 252.
[0127] Compound 3g: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone and 214 mg of DMAP to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 277 mg of 2-fluorobenzoyl chloride dissolved in DCM. After the addition is complete, remove the ice bath and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it over anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a white solid product with a yield of 84%. mp162-163°C; 1 H NMR (600MHz, cdcl3) δ7.95 (t, J=7.6Hz, 1H), 7.58 (q, J=7.1Hz, 1H), 7.25-7.08 (m, 3H), 7.03 (s, 1H), 2.03 (s, 3H). 13 C NMR (150MHz, cdcl3) δ170.98,163.15,162.34,162.31,161.41,141.94,135.69,135.63,1 34.65,132.34,124.17,124.15,117.25,117.11,117.02,116.95,92.95,10.63.HRMS[ESI - ]forC 12 H9FO4[(MH)-], m / zCalcd: 236.20; Found: 236.17.
[0128] Compound 3h: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone and 214 mg of DMAP to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 365 mg of 4-trifluoromethylbenzoyl chloride dissolved in DCM. After the addition is complete, remove the ice bath and react at room temperature for 3 hours. Follow the reaction with TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it over anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a yellow oily product with a yield of 85%. mp16-17°C; 1 H NMR (600MHz, cdcl3) δ8.16 (d, J=7.9Hz, 2H), 7.73 (d, J=7.9Hz, 2H), 7.12 (s, 1H), 7.04 (s, 1H), 2.05 (s, 3H). 13C NMR (150MHz, cdcl3) δ170.76,163.62,141.66,135.54,134.92,131.68,130.45,125.64,93.21,92.31,10.65.HRMS [ESI - ]for C 13 H9F3O4[(MH) - ], m / zCalcd: 286.21; Found: 286.18.
[0129] Compound 3i: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone and 214 mg of DMAP to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 277 mg of 3-fluorobenzoyl chloride dissolved in DCM. After the addition is complete, remove the ice bath and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it over anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a white solid product with a yield of 88%. mp162-163°C; 1 H NMR (600MHz, cdcl3) δ7.85 (dt, J=7.8, 1.3Hz, 1H), 7.72 (ddd, J=9.1, 2.6, 1.5Hz, 1H), 7.45 (td, J=8.0, 5. 4Hz, 1H), 7.32 (tdd, J=8.2, 2.6, 1.0Hz, 1H), 7.13-7.09 (m, 1H), 7.05-7.01 (m, 1H), 2.04 (t, J=1.6Hz, 3H). 13 C NMR (150MHz, cdcl3) δ170.89, 163.66, 161.71, 141.72, 134.78, 130.55, 125.92, 121.06, 116.73, 93.03, 10.58.HRMS [ESI - ]forC 12 H9FO4[(MH)-], m / zCalcd: 236.20; Found: 236.17.
[0130] Compound 3j: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone and 214 mg of DMAP to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 309 mg of 3,4-difluorobenzoyl chloride dissolved in DCM. After the addition is complete, remove the ice bath and react at room temperature for 3 hours. Follow the reaction with TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it with anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a white solid product with a yield of 83%. mp155-156°C; 1 H NMR (600MHz, cdcl3) δ7.89-7.81 (m, 2H), 7.24 (dd, J=8.1, 1.8Hz, 1H), 7.08 (p, J=1.5Hz, 1H), 7.01 (p, J=1.7Hz, 1H), 2.03 (t, J=1.6Hz, 3H). 13 CNMR (150MHz, cdcl3) δ170.79, 162.89, 155.08, 153.46, 151.07, 149.32, 141.59, 134.88, 127.28, 119.26, 93.05, 10.72.HRMS [ESI - ]forC 12 H8F2P4[(MH) - ], m / zCalcd: 254.19; Found: 254.11.
[0131] Compound 3k: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone and 214 mg of DMAP to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 384 mg of 4-bromobenzoyl chloride dissolved in DCM. After the addition is complete, remove the ice bath and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it over anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a white solid product with a yield of 82%. mp124-125°C; 1 H NMR (600MHz, cdcl3) δ7.93-7.87 (m, 2H), 7.64-7.57 (m, 2H), 7.14-7.06 (m, 1H), 7.02 (p, J=1.6Hz, 1H), 2.04 (d, J=1.6Hz, 3H). 13C NMR (150MHz, cdcl3) δ170.91, 164.08, 141.88, 134.75, 132.01, 131.50, 129.36, 127.32, 93.08, 10.66.HRMS [ESI - ]forC 12 H9BrO4[(MH)-], m / zCalcd: 297.10; Found: 297.03.
[0132] Compound 31: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone and 214 mg of DMAP to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 270 mg of 3-methylbenzoyl chloride dissolved in DCM. After the addition is complete, remove the ice bath and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it over anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a white solid product with a yield of 86%. mp166-168°C; 1 H NMR (600MHz, cdcl3) δ7.84 (d, J=10.3Hz, 2H), 7.42 (d, J=7.7Hz, 1H), 7.34 (t, J=7.8Hz, 1H), 7.12 (s, 1H), 7.03 (s, 1H), 2.40 (s, 3H), 2.03 (s, 3H). 13 C NMR (150MHz, cdcl3) 6171.20, 164.39, 164.23, 142.33, 134.41, 132.24, 120.63, 113.89, 92.90, 55.49, 10.63.HRMS [ESI - ]forC 13 H 12 O4[(MH) - ], m / zCalcd: 232.24; Found: 232.12.
[0133] Compound 3m: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone, 214 mg of DMAP, and 335 mg of EDCI to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 298 mg of 4-chloromethylbenzoic acid dissolved in DCM. After the addition is complete, remove the ice bath and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it over anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a white solid product with a yield of 88%. mp123-125°C; 1 H NMR (600MHz, cdcl3) δ 8.11-7.99 (m, 2H), 7.49 (d, J=7.9Hz, 2H), 7.12 (s, 1H), 7.06-6.99 (m, 1H), 4.62 (s, 2H), 2.10-1.96 (m, 3H). 13 C NMR (150MHz, cdcl3) 6171.01, 164.25, 143.45, 141.92, 134.65, 130.57, 128.71, 92.98, 45.12, 10.59.HRMS [ESI - ]forC 13 H 11 ClO4[(MH) - ], m / zCalcd: 266.68; Found: 266.59.
[0134] Compound 3n: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone, 214 mg of DMAP, and 335 mg of EDCI to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 266 mg of 4-methoxybenzoic acid dissolved in DCM. After the addition is complete, remove the ice bath and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it over anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a white solid product with a yield of 90%. mp153-154°C; 1 H NMR (600MHz, cdcl3) δ 8.04-7.94 (m, 2H), 7.16-7.07 (m, 1H), 7.06-6.99 (m, 1H), 6.96-6.89 (m, 2H), 3.87 (d, J=2.8Hz, 3H), 2.09-1.95 (m, 3H). 13C NMR (150MHz, cdcl3) δ171.20, 164.39, 164.23, 142.33, 134.41, 132.24, 120.63, 113.89, 92.90, 55.49, 10.63.HRMS [ESI - ]forC 13 H 12 O5[(MH)-], m / zCalcd: 248.24; Found: 248.16.
[0135] Compound 3o: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone, 214 mg of DMAP, and 335 mg of EDCI to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 296 mg of 4-nitrobenzoic acid dissolved in DCM. After the addition is complete, remove the ice bath and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it over anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a white solid product with a yield of 90%. mp177-179°C; 1 H NMR (600MHz, cdcl3) δ 8.34-8.29 (m, 2H), 8.25-8.20 (m, 2H), 7.13 (p, J = 1.4Hz, 1H), 7.05 (p, J = 1.7Hz, 1H), 2.05 (t, J = 1.6Hz, 3H). 13 C NMR (150MHz, cdcl3) δ171.02, 164.25, 143.45, 142.03, 134.66, 130.49, 128.65, 93.06, 45.13, 10.66.HRMS [ESI - ]forC 12 H9NO6[(MH) - ], m / zCalcd: 263.21; Found: 263.16.
[0136] Compound 3p: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone, 214 mg of DMAP, and 335 mg of EDCI to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 375 mg of 4-phenoxybenzoic acid dissolved in DCM. After the addition is complete, remove the ice bath and react at room temperature for 3 hours. Follow the reaction with TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it with anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a white solid product with a yield of 79%. mp152-153°C; 1 H NMR (600MHz, cdcl3) δ8.03-7.98 (m, 2H), 7.44-7.38 (m, 2H), 7.22 (ddt, J=8.6, 7.4, 1.2Hz, 1H), 7. 11 (p, J=1.4Hz, 1H), 7.09-7.05 (m, 2H), 6.99 (m, 2H), 6.98 (d, J=2.0Hz, 1H), 2.03 (t, J=1.5Hz, 3H). 13 C NMR (150MHz, cdcl3) δ171.20, 164.39, 164.23, 142.33, 134.41, 132.25, 127.32, 120.64, 113.89, 92.90, 55.50, 10.64.HRMS [ESI - ]forC 18 H 14 O5[(MH) - ], m / zCalcd: 310.30; Found: 310.21.
[0137] Compound 3q: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone, 214 mg of DMAP, and 335 mg of EDCI to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 319 mg of 3,5-dimethoxybenzoic acid dissolved in DCM. After the addition is complete, remove the ice bath and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it over anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a white solid product with a yield of 85%. mp152-153°C; 1 H NMR (600MHz, cdcl3) δ7.17 (d, J=2.4Hz, 1H), 7.03 (p, J=1.7Hz, 1H), 6.69 (t, J=2.4Hz, 1H), 3.83 (s, 4H). 13C NMR (150MHz, cdcl3) δ171.06, 164.57, 160.79, 142.06, 134.61, 130.17, 107.61, 106.79, 93.16, 55.64, 10.66.HRMS [ESI - ]forC 13 H 11 O6[(MH) - ], m / zCalcd: 263.23; Found: 263.17.
[0138] Compound 3r: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone, 214 mg of DMAP, and 335 mg of EDCI to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 240 mg of 4-aminobenzoic acid dissolved in DCM. After the addition is complete, remove the ice bath and react at room temperature for 3 hours. Follow the reaction with TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it over anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a white solid product with a yield of 79%. mp160-161°C; 1 HNMR (600MHz, cdcl3) δ7.87-7.82 (m, 2H), 7.10 (t, J=1.5Hz, 1H), 7.00 (q, J=1.6Hz, 1H), 6.66-6.60 (m, 2H), 4.17 (s, 2H), 2.01 (t, J=1.6Hz, 3H). 13 C NMR (150MHz, cdcl3) δ171.37, 164.59, 151.85, 142.59, 134.22, 132.32, 117.42, 113.79, 92.80, 10.63.HRMS [ESI - ]forC 12 H 11 NO4[(MH) - ], m / zCalcd: 233.22; Found: 233.08.
[0139] Compound 3s: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone, 214 mg of DMAP, and 335 mg of EDCI to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 263 mg of 4-ethylbenzoic acid dissolved in DCM. After the addition is complete, remove the ice bath and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it over anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a white solid product with a yield of 82%. mp144-146°C; 1 HNMR (600MHz, cdcl3) δ7.99-7.93 (m, 2H), 7.28 (d, J=8.1Hz, 2H), 7.12 (p, J=1.4Hz, 1H), 7 .03 (p, J=1.6Hz, 1H), 2.71 (q, J=7.6Hz, 2H), 2.03 (t, J=1.6Hz, 3H), 1.26 (t, J=7.6Hz, 3H). 13 C NMR (150MHz, cdcl3) δ171.14, 164.78, 151.11, 142.24, 134.47, 130.22, 128.12, 125.84, 92.96, 29.00, 15.06, 10.64.HRMS [ESI-] forC 14 H 14 O4[(MH) - ], m / zCalcd: 246.26; Found: 246.11.
[0140] Compound 3t: Add 200 mg of 5-hydroxy-3-methyl-2(5H)-furanone, 214 mg of DMAP, and 335 mg of EDCI to a 100 mL eggplant-shaped bottle containing 10 mL of DCM, cool to 0°C in an ice bath, and drop 350 mg of 4-methylsulfonylbenzoic acid dissolved in DCM. After the addition is complete, remove the ice bath and react at room temperature for 3 hours. Follow the reaction by TLC until the reaction is complete. Post-treatment: Add 10 mL of saturated sodium chloride aqueous solution for extraction, collect the organic phase, dry it over anhydrous Na2SO4, and separate and purify it by column chromatography PE:EA (10:1) to obtain a white solid product with a yield of 82%. mp127-129°C; 1 H NMR (600MHz, cdcl3) 68.33-8.16 (m, 1H), 8.09-7.92 (m, 1H), 3.13-3.05 (m, 2H), 2.05 (dt, J=3.4, 1.6Hz, 2H). 13C NMR (150MHz, cdcl3) δ170.72, 163.27, 145.27, 141.58, 135.03, 133.17, 130.99, 127.69, 93.28, 44.25, 10.68.HRMS [ESI - ]forC 13 H 12 06S[(MH)-], m / zCalcd: 296.29; Found: 296.13.
[0141] Example 2 Experiment on the germination of Orobanche and Striga seeds induced by compounds 1a-1y, 2a-2i, 3a-3t
[0142] The germination rates of the compounds 1a-1y, 2a-2i, 3a-3t provided by the present invention and the control drug strigolactone GR24 on the seeds of Striga and Orobanche at a concentration of 10 ppm are as follows:
[0143] Bioassays were conducted using culture dishes to determine the effects of target compounds on the germination rates of Strigosa Striga seeds and Orobancha seeds.
[0144] Drug preparation: Accurately weigh 10 mg of each target compound and dissolve it in 1 mL of DMDO to obtain a 10,000 ppm mother solution. The solutions of each concentration are diluted in a gradient manner from the mother solution. The positive control solution is obtained by gradient dilution of the prepared mother solution.
[0145] Seed pretreatment: Soak the seeds of Orobancha and Striga in 1% NaClO for 2 minutes and 75% alcohol for 2 minutes for surface disinfection, rinse thoroughly with sterile deionized water and dry naturally. Spread a layer of 9cm ordinary filter paper on the bottom of the culture dish, soak it with sterile water, spread a 9mm diameter glass fiber filter paper on the culture dish, and evenly sprinkle the seeds of Orobancha and Striga on the glass fiber filter paper. There are about 50-100 seeds on each piece of glass fiber filter paper. Culture them at 25℃ and dark conditions for 7 days.
[0146] Petri dish bioassay: Cut the filter paper appropriately and lay it flat on the petri dish so that it can fit tightly with the petri dish. Transfer the pre-cultured Orobanche and Striga seeds to the treated petri dish, add 1 mL 10ppm of compounds 1a~1y, 2a~2i, 3a~3t and control drug GR24, 2% DMSO as a negative control, GR24 as a positive control, and 3 replicates for each treatment. After the above operations are completed, transfer them to an artificial climate incubator (22°C, 60% humidity) and culture for 7 days. Observe and count the germination of Orobanche and Striga seeds with a stereo microscope, and calculate the germination rate of Orobanche and Striga as follows:
[0147]
[0148] The effects of target compounds 1a-1y, 2a-2i, 3a-3t and control drug GR24 on the germination of Orobanche and Striga at a concentration of 10 ppm are shown in Table 1:
[0149] Table 1
[0150]
[0151]
[0152] Although the present invention has been described in detail above with general descriptions and specific embodiments, it is obvious to those skilled in the art that some modifications or improvements can be made based on the present invention. Therefore, these modifications or improvements made without departing from the spirit of the present invention all fall within the scope of protection claimed by the present invention.
Claims
1. 5-Hydroxy-3-methylfuran-2(5H)-one derivatives, It is characterized in that The structure is shown in Formula I, Formula II or Formula III: In Formula I, R is selected from 1a to 1y: In formula II, R is selected from 2a to 2i: In formula III, R is selected from 3a to 3t:
2. A method for preparing the 5-hydroxy-3-methylfuran-2(5H)-one derivative according to claim 1, It is characterized in that The preparation method of the compound of formula I comprises: adding a phenol derivative to a tetrahydrofuran solution of 5-chloro-3-methylfuran-2(5H)-one, cooling to 0-5°C, then adding a catalytic amount of potassium tert-butoxide, and reacting at room temperature to obtain the target compound; The structure of the phenol derivative is R-OH, and R is selected from 1a to 1y.
3. The method according to claim 2, It is characterized in that The following steps are involved: Step 1: Add 118.6 mmol of methylmalonic acid and 118.6 mmol of glyoxal into a reaction bottle containing water, add 10 drops of concentrated sulfuric acid, and heat under reflux at 110-115° C. for 10-12 hours to obtain intermediate I, i.e. 5-hydroxy-3-methyl-2(5H)-furanone; Step 2: Add intermediate I to the reaction bottle containing DCM and slowly add SOCl 2 Then, DMF was added, and the mixture was heated under reflux at 90-95° C. for 1-2 h to obtain intermediate II, i.e., 5-chloro-3-methylfuran-2(5H)-one; Step 3: In N 2 Under protection, phenol derivatives and potassium iodide are added to a reaction bottle containing THF, the temperature is lowered to 0-5°C, potassium tert-butoxide is added, stirred for 10-15 minutes, and then intermediate II is added. The reaction is carried out at room temperature for 3-5 hours to obtain the target compound.
4. A method for preparing the 5-hydroxy-3-methylfuran-2(5H)-one derivative according to claim 1, It is characterized in that The preparation method of the compound of formula II comprises: adding a thiophenol derivative to a tetrahydrofuran solution of 5-chloro-3-methylfuran-2(5H)-one, cooling to 0-5°C, then adding a catalytic amount of potassium tert-butoxide, and reacting at room temperature to obtain the target compound; The structure of the thiophenol derivative is R-SH, and R is selected from 2a to 2i.
5. The method according to claim 4, It is characterized in that The following steps are involved: Step 1: Add 118.6 mmol of methylmalonic acid and 118.6 mmol of glyoxal into a reaction bottle containing water, add 10 drops of concentrated sulfuric acid, and heat under reflux at 110-115° C. for 10-12 hours to obtain intermediate I, i.e. 5-hydroxy-3-methyl-2(5H)-furanone; Step 2: Add intermediate I to the reaction bottle containing DCM and slowly add SOCl 2 Then, DMF was added, and the mixture was heated under reflux at 90-95° C. for 1-2 h to obtain intermediate II, i.e., 5-chloro-3-methylfuran-2(5H)-one; Step 3: In N 2 Under protection, thiophenol derivatives and potassium iodide are added to a reaction bottle containing THF, the temperature is lowered to 0-5°C, potassium tert-butoxide is added, stirred for 10 minutes, and then intermediate II is added. The reaction is carried out at room temperature for 3-4 hours to obtain the target compound.
6. A method for preparing the 5-hydroxy-3-methylfuran-2(5H)-one derivative according to claim 1, It is characterized in that The preparation method of the compound of formula III comprises: adding a benzoyl chloride derivative to a dichloromethane solution of 5-hydroxy-3-methyl-2(5H)-furanone, then adding a catalytic amount of DMAP, and reacting at room temperature to obtain the target compound; The structure of the benzoyl chloride derivative is R is selected from 3a to 31.
7. The method according to claim 6, It is characterized in that The following steps are involved: Step 1: Add 118.6 mmol of methylmalonic acid and 118.6 mmol of glyoxal into a reaction bottle containing water, add 10 drops of concentrated sulfuric acid, and heat under reflux at 110-115° C. for 10-12 hours to obtain intermediate I, i.e. 5-hydroxy-3-methyl-2(SH)-furanone; Step 2: Add 1.75 mmol of intermediate I and 1.75 mmol of DMAP to a reaction bottle containing DCM, cool to 0°C, and dropwise add 1.75 mmol of a benzoyl chloride derivative dissolved in dichloromethane. After the addition is complete, react at room temperature for 3-4 hours to obtain the target compound; Wherein, the molar ratio of intermediate I and benzoyl chloride derivative is 1:
1.
8. A method for preparing the 5-hydroxy-3-methylfuran-2(5H)-one derivative according to claim 1, It is characterized in that The preparation method of the compound of formula III comprises: adding 3.5 mmol of a benzoic acid derivative to a dichloromethane solution of 1.75 mmol of 5-hydroxy-3-methyl-2(5H)-furanone, then adding 3.5 mmol of DMAP and 3.5 mmol of EDCI in a catalytic amount, and reacting at room temperature for 3-4 hours to obtain the target compound; The structure of the benzoic acid derivative is R is selected from 3m to 3t.
9. The method according to claim 8, It is characterized in that The following steps are involved: Step 1: Add 118.6 mmol of methylmalonic acid and 118.6 mmol of glyoxal into a reaction bottle containing water, add 10 drops of concentrated sulfuric acid, and heat under reflux at 110-115° C. for 10-12 hours to obtain intermediate I, i.e. 5-hydroxy-3-methyl-2(5H)-furanone; 1:1 Step 2: Add intermediate I, EDCI, and DMAP to a reaction bottle containing DCM, add a benzoic acid derivative dissolved in dichloromethane, and react at room temperature for 3-4h to obtain the target compound; Wherein, the molar ratio of intermediate I and benzoic acid derivative is 1:
2.
10. Any of the following uses of the 5-hydroxy-3-methylfuran-2(5H)-one derivative according to claim 1: (1) Used to induce germination of seeds of Monochamus and Orobancha plants; (2) Used for the prevention and control of monocotyledon and Orobancha plants.
Citation Information
Patent Citations
Thioether strigolactones derivative, preparation method thereof and application of thioether strigolactones derivative in plant growth regulation
CN114773297A
Novel compound having strigolactone-like activity and use thereof
EP2623502A1
Cited By
Preparation method of 5-hydroxy-3-methyl-2 (5H)-furanone
CN120058653A
Use of 5-hydroxy-3-methylfuran-2(5h)-one derivatives in the regulation of plant growth and development
CN122744334A
